Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression

Figure 6 Content of microRNA-142-3p was low in hepatocellular carcinoma tissues and negatively correlated with ASH1L. A: MicroRNA (MiR)-142-3p levels in patients’ tissues as assessed by quantitative real-time polymerase chain reaction; B: Comparison of MiR-142-3p and ASH1L levels in normal liver and hepatocellular carcinoma tissues in the cancer genome atlas; C: Correlation analysis between MiR-142-3p and ASH1L in the cancer genome atlas; D: Immunofluorescence analysis for ASH1L and MiR-142-3p levels in MHCC-97H cells. ^cP < 0.001. MiR: MicroRNA.